Rankings
▼
Calendar
ACH (Accendra Health, Inc.) Stock Financials & Earnings | Market Cap Arena
ACH
Accendra Health, Inc.
Mkt Cap
$185M
Healthcare
·
Medical - Distribution
·
🇺🇸 United States
·
NYSE
Revenue (TTM)
$4.7B
Net Income (TTM)
-$1.1B
EPS (TTM)
-$14.29
Free Cash Flow (TTM)
-$305M
Gross Margin
31.0%
Op. Margin
0.2%
Net Margin
-23.3%
FCF Margin
-6.5%
P/S Ratio (TTM)
0.0x
P/E Ratio (TTM)
—
YoY Rev Growth
-29.1%
Employees
—
Earnings Reports
▶
Q4 2025
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$2.5B
$497M
$10M
Q2 23
$2.6B
$519M
$11M
Q3 23
$2.6B
$538M
$24M
Q4 23
$2.7B
$570M
$60M
Q1 24
$2.6B
$536M
$10M
Q2 24
$660M
$316M
$17M
Q3 24
$687M
$332M
$31M
Q4 24
$2.7B
$580M
-$262M
Q1 25
$2.6B
$526M
$124K
Q2 25
$682M
$325M
-$40M
Q3 25
$697M
$322M
$26M
Q4 25
$709M
$290M
$22M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
0.0x
—
Q2 23
0.0x
—
Q3 23
0.0x
—
Q4 23
0.0x
—
Q1 24
0.0x
—
Q2 24
0.0x
—
Q3 24
0.0x
—
Q4 24
0.0x
—
Q1 25
0.0x
—
Q2 25
0.0x
—
Q3 25
0.0x
—
Q4 25
0.0x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
$158M
$107M
Q2 23
$313M
$264M
Q3 23
$157M
$107M
Q4 23
$112M
$55M
Q1 24
-$53M
-$102M
Q2 24
$116M
$70M
Q3 24
$27M
-$34M
Q4 24
$71M
$8M
Q1 25
-$35M
-$100M
Q2 25
$38M
-$30M
Q3 25
-$173M
-$230M
Q4 25
$68M
$55M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$51M
Q2 23
$49M
Q3 23
$51M
Q4 23
$56M
Q1 24
$49M
Q2 24
$46M
Q3 24
$62M
Q4 24
$63M
Q1 25
$65M
Q2 25
$68M
Q3 25
$58M
Q4 25
$13M
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
+4.8%
+7.1%
Q2 23
+2.5%
+5.3%
Q3 23
+3.8%
+5.4%
Q4 23
+4.1%
-0.3%
Q1 24
+3.6%
+3.6%
Q2 24
-74.2%
-74.8%
Q3 24
-73.5%
-74.5%
Q4 24
+1.5%
+13.9%
Q1 25
+0.7%
+1.1%
Q2 25
+3.3%
+12.1%
Q3 25
+1.5%
+2.3%
Q4 25
-73.7%
-76.8%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$6M
0.3%
Q2 23
$5M
0.2%
Q3 23
$6M
0.2%
Q4 23
$6M
0.2%
Q1 24
$7M
0.3%
Q2 24
$7M
1.0%
Q3 24
$6M
0.8%
Q4 24
$8M
0.3%
Q1 25
$7M
0.3%
Q2 25
$5M
0.7%
Q3 25
$2M
0.3%
Q4 25
$4M
0.5%
marketcaparena.com
OpEx Breakdown
R&D
G&A
S&M
SG&A
Quarter
R&D
G&A
S&M
SG&A
Q1 23
—
—
$449M
—
Q2 23
—
—
$455M
—
Q3 23
—
—
$453M
—
Q4 23
$13M
$1.8B
—
—
Q1 24
—
—
$478M
—
Q2 24
—
—
$469M
—
Q3 24
—
—
$470M
—
Q4 24
—
$101M
—
—
Q1 25
—
—
$462M
—
Q2 25
—
—
—
$268M
Q3 25
—
—
—
$266M
Q4 25
—
—
—
$269M
marketcaparena.com
Revenue Segments
Patient Direct
Products & Healthcare Services
Diabetes Product
Product and Service, Other
Urology
Wound Care
Quarter
Patient Direct
Products & Healthcare Services
Diabetes Product
Product and Service, Other
Urology
Wound Care
Q1 23
$607M
$1.9B
—
—
—
—
Q2 23
$633M
$1.9B
—
—
—
—
Q1 24
$638M
$2.0B
—
—
—
—
Q4 24
$695M
$2.0B
—
—
—
—
Q1 25
$674M
$2.0B
—
—
—
—
Q4 25
—
—
$391M
$143M
$58M
$94M
marketcaparena.com
Revenue by Geography
Non-US
United States
Quarter
Non-US
United States
Q1 23
$70M
$2.5B
Q2 23
$65M
$2.5B
Q3 23
$73M
$2.5B
Q4 23
$68M
$2.6B
Q1 24
$62M
$2.6B
Q4 24
$59M
$2.6B
Q1 25
$51M
$2.6B
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$67M
$0
$67M
Q2 23
$286M
$0
$286M
Q3 23
$215M
$0
$215M
Q4 23
$243M
$0
$243M
Q1 24
$245M
$0
$245M
Q2 24
$257M
$0
$257M
Q3 24
$45M
$0
$45M
Q4 24
$49M
$0
$49M
Q1 25
$59M
$0
$59M
Q2 25
$38M
$0
$38M
Q3 25
$33M
$0
$33M
Q4 25
$282M
$0
$282M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
75M
+0.2%
Q2 23
76M
+0.8%
Q3 23
76M
+0.5%
Q4 23
78M
+2.1%
Q1 24
76M
-1.9%
Q2 24
77M
+0.5%
Q3 24
77M
+0.5%
Q4 24
77M
+0.1%
Q1 25
77M
+0.1%
Q2 25
77M
-0.4%
Q3 25
77M
+0.5%
Q4 25
77M
-0.8%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 14
$2M
6K
FY 15
$2M
6K
FY 16
$2M
6K
FY 17
$2M
6K
FY 18
$1M
7K
FY 19
$1M
6K
FY 20
$1M
6K
FY 21
$1M
7K
FY 22
$743K
13K
FY 23
$754K
14K
FY 24
$793K
14K
FY 25
$205K
14K
marketcaparena.com